Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Ins & Outs of Patient Assistance Programs

Samantha C. Shapiro, MD  |  March 3, 2022

Genentech Access to Care Foundation

mycophenolate mofetil (CellCept)

(888) 754-7651 Lilly Cares

ixekizumab (Taltz)

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

baricitinib (Olumiant)

(800) 545-6962 GSK Benlysta Cares

belimumab (Benlysta)

(877) 423-6597 Takeda Help at Hand

colchicine (Colcrys)

(800) 830-9159 Sobi Kineret on Track

anakinra (Kineret)

(866) 547-0644 Horizon Patient Services

pegloticase (Krystexxa)

(877) 633-9521 UCB Cares

certolizumab pegol (Cimzia)

(877) 785-8906

Takeaways

PAPs can help uninsured patients obtain access to biologic medications. Calling PAP phone numbers is refreshingly easy, and the staff are helpful. Some patients, especially those who don’t speak English, will benefit from your team’s help to complete the application process. Although the PAP process is imperfect and requires extra work on the provider’s part, the benefit to uninsured patients with rheumatic disease is priceless. Literally.


Samantha C. Shapiro, MD, is an academic rheumatologist and an affiliate faculty member of the Dell Medical School at the University of Texas at Austin. She received her training in internal medicine and rheumatology at Johns Hopkins University, Baltimore. She is also a member of the ACR Insurance Subcommittee.

References

  1. Position statement on access to biologics. American College of Rheumatology. 2021 Aug.
  2. Keisler-Starkey K and Bunch LN. Health insurance coverage in the United States: 2020. United States Census Bureau. 2021 Sept 14.
  3. Addington WW. No health insurance? It’s enough to make you sick—Scientific research linking the lack of health coverage to poor health. American College of Physicians policy statement. 1999.
  4. Patel V, Patel R, Hackshaw K. Rheumatology care for the underserved in Central Texas [abstract]. Arthritis Rheumatol. 2021 Oct;73(suppl 10).
ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Biologics/DMARDsDrug UpdatesPractice Support Tagged with:biologic therapiesdrug costsfederally qualified health centerpatient assistance programs (PAP)patient careuninsured Americans

Related Articles

    Combine With Medicare Part D to Help Patients Afford Prescriptions

    February 1, 2007

    According to the 2003 U.S. Census, 29 million people in the United States make less than 200% of the federal poverty level and have no health insurance. Many persons have difficulty affording prescribed medications. In addition to Medicare Part D, there are more than 350 public and private patient assistance programs, including programs by pharmaceutical companies, that help patients pay for prescriptions.

    Colcrys Approval Triggers Questions

    May 1, 2010

    Some rheumatologists question the depth of research and the approval’s implications for patient access

    Drug Assistance Programs Offer Little Charity to Uninsured

    August 7, 2019

    (Reuters Health)—Many patients who receive assistance from charities set up to defray prescription drugs costs may already have insurance that covers most the cost for their medications, a U.S. study suggests. Researchers examined data on the six largest independent charities offering patient assistance programs through 274 different disease-specific programs. These programs had total revenue ranging…

    U.S. Uninsured Rate Up by Most in Nearly a Decade

    January 16, 2018

    WASHINGTON (Reuters)—The number of Americans without health insurance rose by 3.2 million people between 2016 and 2017, or 1.3% points to 12.2%, according to a Gallup poll released on Tuesday, the biggest jump in the uninsured rate in nearly a decade.1 Several factors likely contributed to the jump, Gallup said, including attempts by Republicans, who…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences